Oestrogens and Psychological Well-being

References

• Buchanan C M, Eccles J S, Becker J B. Are adolescents victims of raging hormones: evidence for activational effects of hormones on moods and behavior at adolescence?. Psychol Bull 1992; 111: 62–107
   PubMed Web of Science ®Google Scholar
• Paikoff R L, Brooks-Gunn J, Warren M. Predictive effects of hormonal change on affective expression in adolescent females over the course of one year. J Youth Adolesc 1991; 20: 191–214
   PubMed Web of Science ®Google Scholar
• Bancroft J. The premenstrual syndrome - a reappraisal of the concept and the evidence. Psychol Med 1993; 1–47, Suppl 24
   PubMedGoogle Scholar
• Pearlstein T. Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy?. Am J Obstet Gynecol 1995; 173: 646–53
   PubMed Web of Science ®Google Scholar
• Mortola J. Assessment and management of premenstrual syndrome. Curr Opin Obstet Gynecol 1992; 4: 877–85
   PubMed Web of Science ®Google Scholar
• Warner P, Bancroft J, Dixson A, Hampson M. The relationship between perimenstrual depressive mood and depressive illness. J Affect Disord 1991; 23: 9–23
   PubMed Web of Science ®Google Scholar
• Bancroft J, Rennie D, Warner P. Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder. Psychosom Med 1994; 56: 225–31
   PubMed Web of Science ®Google Scholar
• Halbreich U, Endicott J, Goldstein S, Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 1986; 74: 576–86
   PubMed Web of Science ®Google Scholar
• Rubinow D R, Schmidt P J. The neuroendocrinology of menstrual cycle mood disorders. Ann NY Acad Sci 1995; 771: 648–59
   PubMedGoogle Scholar
• Rubinow D R, Hoban N IC, Grover G N, et al. Premenstrual mood disorder and psychiatric illness. Am J Psychiatry 1985; 142: 1359–61
   PubMedGoogle Scholar
• Rapkin A J, Edelmuth E, Chang L C, Reading A E, McGuIre M T, Su T. Whole-blood serotonin in premenstrual syndrome. Otostef. Gynecol 1987; 70: 533–7
   Google Scholar
• Watts J F, Butt W R, Logan-Edwards R, Holder G. Hormonal studies in women with premenstrual tension. Br J Obstet Gynaecol 1985; 92: 247–55
   PubMedGoogle Scholar
• Schmidt P J, Purdy R H, Moore P H, Jr, Paul S M, Rubinow D R. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 1994; 79: 1256–60
   PubMed Web of Science ®Google Scholar
• Halbreich U, Piletz J E, Carson S, Halaris A, Rojansky N. Increased imidazoline and alpha-2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry 1993; 34: 676–86
   PubMedGoogle Scholar
• Rapkin A J. The role of serotonin in premenstrual syndrome. Clin Obstet Gynecol 1992; 35: 629–36
   PubMed Web of Science ®Google Scholar
• Parry B L, Berga S L, Kripke D F, et al. Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression. Arch Gen Psychiatry 1990; 47: 1139–46
   PubMed Web of Science ®Google Scholar
• Freeman E, Rickels K, Sondheimer S. Fluvoxamine for premenstrual dysphoric disorder: a pilot study. J Clin Psychiatry 1996; 57: 56–60
   PubMedGoogle Scholar
• Eriksson E, Hedberg M A, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropharmacology 1995; 12: 167–76
   Google Scholar
• Pearlstein T B, Stone A B. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994; 55: 332–5
   PubMed Web of Science ®Google Scholar
• Graham C A, Sherwin B B. A prospecive treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992; 36: 257–66
   PubMed Web of Science ®Google Scholar
• Bancroft J, Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 1993; 37: 195–202
   PubMed Web of Science ®Google Scholar
• Walker A, Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study. Psychosom Med 1990; 52: 86–96
   PubMed Web of Science ®Google Scholar
• Halbreich U, Holtz I, Paul L. Premenstrual changes: impaired hormonal homeostasis. Endocrinol Metab Clin North Am 1988; 17: 173–94
   PubMed Web of Science ®Google Scholar
• Parry B B. Reproductive factors affecting the course of affective illness in women. Womens Disord 1989; 12: 207–20
   Google Scholar
• Wagner K D, Berenson A B. Norplant associated major depression and panic disorder. J Clin Psychiatry 1994; 55: 478–80
   PubMed Web of Science ®Google Scholar
• Grant E CG, Pryse-Davies J. Effects of oral contraceptives on depressive mood changes and on monoamine oxidase and phosphatases. BMJ 1968; 3: 777–80
   PubMed Web of Science ®Google Scholar
• Lewis A, Hoghughi M. An evaluation of depression as a side effect of oral contraceptives. Br J Psychiatry 1969; 115: 697–701
   PubMedGoogle Scholar
• Rickels K, Garcia C R, Lipman R S, et al. The Hopkins symptom checklist. Assessing emotional distress in an obstetric-gynecologic practice. Prim Care 1976; 3: 751–64
   PubMedGoogle Scholar
• Kay C R. The Royal College of General Practitioners' oral contraception study: some recent observations. Clin Obstet Gynaecol 1984; 11: 759–86
   PubMedGoogle Scholar
• Cullberg J. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. Acta Psychiatr Scand Suppl 1972; 236: 1–86
   PubMedGoogle Scholar
• Slap G B. Oral contraceptives and depression. J Adolesc Health Care 1981; 2: 53–64
   PubMedGoogle Scholar
• Fleming O, Seager C R. Incidence of depressive symptoms in users of oral contraceptive. Br J Psychiatry 1978; 132: 431–40
   PubMed Web of Science ®Google Scholar
• Mishell D R, Jr. The pharmacologic and metabolic effects of oral contraceptives. Int J Pert 1989; 34(Suppl)21–6
   Google Scholar
• Deijen J B, Duyn K J, Jansen W A, Klitsie J W. Use of a monophasic, low-dose oral contraceptive in relation to mental functioning. Contraception 1992; 46: 359–67
   PubMed Web of Science ®Google Scholar
• Bancroft J, Sartorius N. The effects of oral contraceptives on well-being and sexuality. Oxf Rev Reprod Biol 1990; 12: 57–92
   PubMedGoogle Scholar
• Parry B L, Rush A J. Oral contraceptives and depressive symptomatology: biologic mechanisms. Compr Psychiatry 1979; 20: 347–58
   PubMed Web of Science ®Google Scholar
• Kutner J S, Brown-Willard L. History of depression as a risk factor for depression with oral contraceptives and discontinuance. J Nerv Ment Dis 1972; 155: 163–9
   PubMedGoogle Scholar
• Kendler K S, Martin N G, Heath A C, Handelsman D, Eaves L J. A twin study of the psychiatric side effects of oral contraceptives. J Nerv Ment Dis 1988; 176: 153–60
   PubMed Web of Science ®Google Scholar
• Moller S. Effect of oral contraceptives on tryptophan and tyrosine availability: evidence for a possible contribution to mental depression. Neuropsychobiology 1981; 7: 192–200
   PubMed Web of Science ®Google Scholar
• Shaarawy M, Fayad M, Nagui A R, Abdel-Azim S. Serotonin metabolism and depression in oral contraceptive users. Contraception 1982; 26: 193–204
   PubMedGoogle Scholar
• O'Hara M W, Schleche J A, Lewis D A, Wright E J. Prospective postpartum blues. Biologic and psychosocial factors. Arch Gen Psychiatry 1991; 48: 801–6
   PubMed Web of Science ®Google Scholar
• Stowe Z N, Nemeroff C B. Women at risk for postpartum-onset major depression. Am J Obstet Gynecol 1995; 173: 639–45
   PubMed Web of Science ®Google Scholar
• Sichel D A, Cohen L S, Robertson L M, Ruttenberg A, Rosenbaum J F. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995; 38: 814–8
   PubMed Web of Science ®Google Scholar
• Handley S L, Dunn T L, Baker J M, Cockshott C, Gould S. Mood changes in the puerperium, and plasma tryptophan and Cortisol concentrations. BMJ 1977; 2: 18–20
   PubMedGoogle Scholar
• Handley S L, Dunn T L, Waldron G, Baker J M. Tryptophan, Cortisol and puerperal mood. Br J Psychiatry 1980; 136: 498–508
   PubMed Web of Science ®Google Scholar
• Goldani von Muhlen D, Kritz-Silverstein D, Barret-Connor E. A community-based study of menopause symptoms and estrogen replacement in older women. Maturitas 1995; 22: 71–8
   PubMedGoogle Scholar
• Woods N F, Mitchell E S. Patterns of depressed mood in midlife women: observations from the Seattle Midlife Women's Health Study. Res Nurs Health 1996; 19: 111–23
   PubMed Web of Science ®Google Scholar
• Groeneveld M J, Bareman F P, Barentsen R, Dokter H J, Drogendijk A C, Hoes A W. The climacteric and well-being. J Psychosom Obstet Gynecol 1993; 14: 127–43
   PubMed Web of Science ®Google Scholar
• Hay A G, Bancroft J, Johnstone E C. Affective symptoms in women attending a menopause clinic. Br J Psychiatry 1994; 164: 513–6
   PubMed Web of Science ®Google Scholar
• Stewart D E, Boydell K M, Derzko C, Marshall V. Psychologic distress during the menopausal years in women attending a menopause clinic. Int J Psychiatry Med 1992; 22: 213–20
   PubMed Web of Science ®Google Scholar
• Stewart D E, Boydell K M. Psychologic distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 1993; 23: 157–62
   PubMed Web of Science ®Google Scholar
• Vliet E L, Hutcheson-Davis V L. New perspectives on the relationship of hormone changes to affective disorders in the perimenopause. NAACOGS Clin Issues 1991; 2: 453–71
   Google Scholar
• Palinkas L A, Barret-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992; 80: 30–6
   PubMed Web of Science ®Google Scholar
• Sherwin B B. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996; 87: 20S–6S
   PubMed Web of Science ®Google Scholar
• Nathorst-Boos J, von-Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy -effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynecol 1993; 14: 283–93
   PubMed Web of Science ®Google Scholar
• Backstrom T. Symptoms related to the menopause and sex steroid treatments. Ciba Found Symp 1995; 191: 171–80
   PubMedGoogle Scholar
• Ditkoff E C, Crary W G, Cristo M, Lobo R A. Estrogen improves the psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991; 78: 991
   PubMed Web of Science ®Google Scholar
• Klaiber E L, Broverman D M, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979; 36: 550–4
   PubMed Web of Science ®Google Scholar
• Matthews K A. Myths and realities of the menopause. Psychosom Med 1992; 54: 1–9
   PubMed Web of Science ®Google Scholar
• Gambrell D R. Hormone Replacement Therapy, 4th edn. Essential Medical Information Systems, Inc., Durant, OK 1995
   Google Scholar
• Sommer B. Cognitive performance and the menstrual cycle. Cognition and the Menstrual Cycle, J TE Richardson. Springer-Verlag, New York 1992; 39–66
   Google Scholar
• Phillips S M, Sherwin B B. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 1992; 17: 497–506
   PubMed Web of Science ®Google Scholar
• Kampen D L, Sherwin B B. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994; 83: 979–83
   PubMed Web of Science ®Google Scholar
• Phillips S M, Sherwin B B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17: 485–95
   PubMed Web of Science ®Google Scholar
• Sherwin B B, Tulandi T. Add-back' estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 1996; 81: 2545–9
   PubMed Web of Science ®Google Scholar
• Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 1995; 29: 312–21
   PubMed Web of Science ®Google Scholar
• Honjo H, Tanaka K, Kashiwagi T, et al. Senile dementia -Alzheimer's type and estrogen. Horm Metab Res 1994; 27: 204–7
   Google Scholar
• Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994; 41: 361–71
   PubMed Web of Science ®Google Scholar
• Sherwin B B. Estrogenic effects on memory in women. Ann NY Acad Sci 1994; 743: 213–30
   PubMed Web of Science ®Google Scholar
• Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995; 37: 434–41
   PubMed Web of Science ®Google Scholar
• Lippert T H, Filshie M, Muck A O, Seeger H, Zwirner M. Serotonin metabolite excretion after postmenopausal estradiol therapy. Maturitas 1996; 24: 37–41
   PubMed Web of Science ®Google Scholar
• Fink G, Sumner B EH, Rosie R, Grace O, Quinn J P. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 1996; 16: 325–44
   PubMed Web of Science ®Google Scholar
• Pfaff D W, McEwen B S. Actions of estrogens and progestins on nerve cells. Science 1983; 219: 808–14
   PubMed Web of Science ®Google Scholar
• Maswood S, Sterwrt G, Uphouse L. Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin. Pharmacol Biochem Behav 1995; 51: 807–13
   PubMedGoogle Scholar
• Clarke W P, Maayani S. Estrogen effects on 5-HT1A receptors in hippocampal membranes from ovariectomized rats: functional and binding studies. Brain Res 1990; 518: 287–91
   PubMedGoogle Scholar
• Leibenluft E. Do gonadal steroids regulate circadian rhythms in humans?. J Affect Disord 1993; 29: 175–81
   PubMed Web of Science ®Google Scholar
• Partonen T. Estrogen could control photoperiodic adjustment in seasonal affective disorder. Med Hypotheses 1995; 45: 35–6
   PubMedGoogle Scholar